Kettering Health Network
Trial Pipeline
Comparing Prism Adaptation Training With and Without TENS to Minimize Unilateral Spatial Neglect
NCT07157865
Exparel and Education to Avoid Opioids After Carpal Tunnel Release
NCT03867539
Single Blinded First CMC Osteoarthritis Treatment
NCT03196310
The Effect of Video Education on Skin-to-Skin at the Time of Delivery
NCT03200925
Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer
NCT02287675
PO vs. IV Acetaminophen Given Perioperatively for 24 hr Post-op Pain Control Following Total Hip or Knee Replacement
NCT02244619
Effect of Oasis® Wound Matrix on Stage III and IV Trunk Pressure Wounds Treated With Negative Pressure Wound Therapy
NCT02246608
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 3 |
Therapeutic Areas
What the Pipeline for Kettering Health Network Shows
According to the ClinicalTrials.gov registry, Kettering Health Network is linked to 34 US clinical trials across every stage of research activity. Of those, 30 studies are currently recruiting — about 88% of the sponsor's indexed portfolio — and 4 are already marked complete, representing roughly 12% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for Kettering Health Network reports 3 late-stage studies (Phase 3 and Phase 4 combined) and 0 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for Kettering Health Network is Skin-to-skin with 1 linked trial, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.